Enterprise League logo
V

VASCULAR BIOSCIENCES, INC.

DURHAM, United States (US) · Health and Medical

Source

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Work here? Claim this profile

Overview

Vascular BioSciences, Inc is a Durham, North Carolina-based biotechnology company specializing in innovative solutions for serious diseases.

We develop targeted therapies, including our lead CAR peptide, CARSKNKDC, designed to enhance the efficacy of treatments for pulmonary hypertension, COVID-19, and sepsis.

Our core expertise lies in combining interventional technology – exemplified by our world’s first endoarterial biopsy catheter – with advanced molecular diagnostics, offering a comprehensive approach to vascular disease management. We are dedicated to pioneering disease-selective therapies and improving patient outcomes, driven by a mission to enhance and prolong human life, much like we would care for our own family.

Vascular BioSciences is committed to advancing medical science through groundbreaking research and development, ultimately transforming the landscape of vascular disease treatment.

Most teams do this before shortlisting


Contact Details

info@vascularbiosciences.com

DURHAM, United States (US)

Employees

2-10

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after VASCULAR BIOSCIENCES, INC.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.